Current Report Filing (8-k)
December 09 2021 - 4:16PM
Edgar (US Regulatory)
0000715446
false
0000715446 2021-12-07
2021-12-07 iso4217:USD
xbrli:shares
iso4217:USD xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or Section 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): December
7, 2021
ANIXA
BIOSCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-37492
|
|
11-2622630
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification
No.)
|
3150
Almaden Expressway,
Suite
250
San
Jose, CA
|
|
95118
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (408)
708-9808
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under
any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.01 per share
|
|
ANIX
|
|
The
NASDAQ Stock Market LLC
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.08.
|
Shareholder
Director Nominations.
|
On
December 7, 2021, the Board of Directors of Anixa Biosciences, Inc. (the “Company”) determined that the Company’s
2022 Annual Meeting of Stockholders (the “Annual Meeting”) will be held on Thursday, March 10, 2022. It is expected
that the Annual Meeting will be held virtually on the internet, but the time and location of the Annual Meeting will be as set forth
in the Company’s definitive proxy statement for the Annual Meeting to be filed with the Securities and Exchange Commission (“SEC”).
Pursuant to the Company’s Amended and Restated Bylaws (the “Bylaws”), stockholders seeking to bring business
before the Annual Meeting or to nominate candidates for election as directors at the Annual Meeting must deliver such proposals or nominations
to the principal executive offices of the Company, at 3150 Almaden Expressway, Suite 250, San Jose, CA 95118, Attention: Corporate Secretary,
not later than January 10, 2022 which the Board of Directors has determined is a reasonable time before the date on which the Company
begins to print and mail its proxy materials. Any stockholder proposal or director nomination must comply with the processes and procedures
outlined in the Bylaws and must also comply with the requirements of Delaware law and the rules and regulations promulgated by the Securities
and Exchange Commission, as applicable.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated:
December 9, 2021
|
|
|
|
|
|
|
ANIXA
BIOSCIENCES, INC.
|
|
|
|
|
By:
|
/s/
Amit Kumar
|
|
Name:
|
Dr.
Amit Kumar
|
|
Title:
|
President
and Chief Executive Officer
|
Anixa Biosciences (NASDAQ:ANIX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anixa Biosciences (NASDAQ:ANIX)
Historical Stock Chart
From Apr 2023 to Apr 2024